Said Saim
Chief Tech/Sci/R&D Officer at EYEPOINT PHARMACEUTICALS, INC.
Profile
Said Saim is currently working as the Chief Technology Officer & Senior VP at EyePoint Pharmaceuticals, Inc. Prior to his current position, he worked as the Senior Director-Pharmaceutical Development at Collegium Pharmaceutical, Inc. from 2008 to 2013.
He also held the position of Principal Scientist at Boehringer Ingelheim Pharmaceuticals, Inc. and Assistant Research Professor at Higuchi Bioscience Center.
Dr. Saim completed his graduate and doctorate degrees at the University of Kansas.
Said Saim active positions
Companies | Position | Start |
---|---|---|
EYEPOINT PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-06-09 |
Former positions of Said Saim
Companies | Position | End |
---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Higuchi Bioscience Center | Corporate Officer/Principal | - |
COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | - |
Training of Said Saim
University of Kansas | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Higuchi Bioscience Center |
- Stock Market
- Insiders
- Said Saim